arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

BillionToOne, Inc.

BLLN
$93.36 ▲ +1.71 (+1.87%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
10 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
57
Health
Fair
Bullish
auto_awesome

Analytical Summary

BillionToOne, Inc. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $4.3B
Dividend Yield
Revenue Growth 83.8%
Op. Margin 16.5%
ROIC 2.9%
FCF / Share $0.24
Trailing P/E 239.4x
Price / Book 8.5x
FCF Yield 0.3%
Debt / Equity 0.18
info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$108.39M
↑ +83.8%
Net Income Profit after all expenses
$17.97M
↑ +200.7%
Operating Margin Operating profit as % of sales
16.5%
↑ +53.0% 43th
FCF / Share Free cash flow per share
$0.24
↑ +785.1%
Long-Term Debt Long-term obligations
$90.00M
↑ +57.3%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
43
Returns
47
Financial Health
74
Cash Quality
87

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 10 quarters